Latest pruritus Stories

2014-03-21 12:22:51

CANTERBURY, England, March 21, 2014 /PRNewswire/ -- - Phase 2b data demonstrates a 60% reduction in pruritus in psoriatic patients treated with CT327 - Data analysis also published in the Journal of the American Academy of Dermatology - Phase 2b CT327 topline data in patients with Atopic Dermatitis and Pruritus due in mid-2014 Creabilis Ltd, the dermatology company with the most advanced targeted topical...

2011-11-10 08:00:00

New treatment may offer a new option in the care of patients with pruritus. (PRWEB) November 10, 2011 Toray Industries, Inc. (headquarters: Chuo-ku, Tokyo; President, CEO and COO: Akihiro Nikkaku; hereinafter referred to as âœTorayâ) and Mitsubishi Tanabe Pharma Corporation (headquarters: Chuo-ku, Osaka; President and CEO: Michihiro Tsuchiya; hereinafter referred to as âœMitsubishi Tanabe Pharmaâ) announced that the...

2009-11-02 07:00:00

BOSTON, Nov. 2 /PRNewswire/ -- Ocera Therapeutics, Inc. announced today that AST-120 (spherical carbon adsorbent) was shown to reduce the severity of pruritus (itching) in patients with chronic liver disease. The data were presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases in a presentation titled, "Oral AST-120 (Spherical Carbon Adsorbent) Improves Pruritus and Lowers Serum Bile Acids in Patients with Cirrhosis of Various Etiologies." These...

2009-03-06 09:00:00

- Interim Findings To Be Presented in a Poster Session at the 67th Annual Meeting of the American Academy of Dermatology - SAN FRANCISCO, March 6 /PRNewswire/ -- Galderma Laboratories, L.P. today announced interim findings from a study of sequential treatment of plaque psoriasis using Clobex(R) (clobetasol propionate) Spray 0.05% followed by treatment with Vectical(TM) (calcitriol) Ointment 3mcg/g. The results of an interim analysis of the data are to be presented in a poster session at the...

Word of the Day
  • Boughs or branches.
  • Warbling of birds in trees.